Daisy Maria Obispo

Ms. Daisy Maria Obispo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2024 in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Verified
Journal Article
Open access
RSRodrigo Sánchez
Rodrigo Sánchez
OAOscar Acosta
Oscar Acosta
LLLina Laymito
Lina Laymito
TOTeodoro J. Oscanoa
Teodoro J. Oscanoa
MGMaría L. Guevara-Fujita
María L. Guevara-Fujita
RFRicardo FUJITA
Ricardo FUJITA
Tuberculosis (TB) is a highly prevalent chronic infectious disease in developing countries, with Peru being one of the most affected countries in the world. The variants of the N-acetyltransferase 2 (NAT2) gene are related to xenobiotic metabolism and have potential usefulness in TB studies. To determine whether NAT2 gene variants and acetylator phenotypes are associated with active TB in Peruvian patients. This study included cases (patients with TB) and controls (population-based data). First, DNA isolation and the rs1799929, rs1799930, and rs1799931 variants of the NAT2 gene were identified using sequencing methods. Subsequently, the acetylator phenotypes, namely slow (SA), intermediate (IA), and rapid acetylation (RA), were also analyzed. The comparison of the frequencies of the rs1799931 variant in the cases and controls revealed significant differences. Risk factors were found for both the A allele (p = 0.00; odds ratio [OR] = 3.04, 95 % confidence interval [CI]: 1.88–4.9) and AG genotype (p = 0.00; OR = 5.94, 95 % CI: 3.17–11.09). In addition, the non-rapid acetylator phenotype (SA + IA) was also found to be a risk factor (p = 0.016; OR = 3.16, 95 % CI: 1.29–7.72). The A allele, GA heterozygous genotype of the rs1799931 variant of the NAT2 gene, and SA + IA acetylator phenotype showed an association with increased risk for the development of TB. In addition to xenobiotic metabolism, other metabolic and immunological functions of NAT2 have also been postulated to confer susceptibility to TB in the Peruvian population owing to its characteristic high Native American component.

30 October 2024 in Viruses
Verified
Journal Article
Open access
PDF file
DODaisy Maria Obispo
Daisy Maria Obispo
OAOscar Acosta
Oscar Acosta
MGMaría L. Guevara-Fujita
María L. Guevara-Fujita
SESusan Echavarría
Susan Echavarría
SESusan Espetia
Susan Espetia
RFRicardo FUJITA
Ricardo FUJITA
The accurate determination of an individual’s unique human leukocyte antigen (HLA) allele holds important significance in evaluating the risk associated with autoimmune and infectious diseases, such as human immunodeficiency virus (HIV) infection. Several allelic variants within the HLA system have been linked to either increased protection or susceptibility in the context of infectious and autoimmune diseases. This study aimed to determine the frequency and association of HLA alleles between people living with HIV (PLHIV) as the case group and Peruvian individuals without HIV with high-risk behaviors of sexually transmitted diseases as the control group. Whole exome sequencing (WES) was used to determine high-resolution HLA allelotypes using the OptiType and arcas HLA tools. The HLA alleles present in HLA classes I (A, B, and C loci) and II (DPB1, DQA1, DQB1, and DRB1 loci) were determined in a cohort of 59 PLHIV (cases) and 44 individuals without HIV (controls). The most frequent HLA alleles were A*02:01, DPB1*04:02, and DQB1*03:419 at 36%, 30%, and 28% prevalence in general population. We found that C*07:01 (p = 0.0101; OR = 10.222, 95% IC: 1.40–74.55), DQA1*03:02 (p = 0.0051; OR = 5.297, 95% IC: 1.48–19.02), and DRB1*09:01 (p = 0.0119; OR = 4.788, 95% IC: 1.39–16.44) showed an association with susceptibility to HIV infection, while DQB1*03:419 (p = 0.0478; OR = 0.327, 95% IC: 0.11–0.96) was associated with protection from HIV infection. Our findings contribute to the knowledge of HLA allele diversity in the Peruvian population (around 70% South American indigenous ancestry) lays the groundwork for further valuable large-scale use of HLA typing and offers a novel association with HIV infection that is relevant to vaccine studies.

Verified
Journal Article
Open access
PDF file
OAOscar Acosta
Oscar Acosta
AMAngelo Motta
Angelo Motta
JBJosé Luis Buleje
José Luis Buleje
Alexis Murillo CarrascoAlexis Murillo Carrasco
Alexis Murillo Carrasco
DODaisy Maria Obispo
Daisy Maria Obispo
RFRicardo FUJITA
Ricardo FUJITA
MicroRNAs (miRNAs) are small non-coding sequences that regulate gene expression at the post-transcriptional level in various biological processes (including differentiation, cell proliferation, cell cycle and apoptosis). Low levels of human miRNA-145 (hsa-miRNA-145) expression have been found in the plasma of cancer patients, suggesting that it is a tumor suppressor. Newly developed molecular biology technologies such as digital PCR (dPCR) have high sensitivity and specificity for evaluating miRNAs, with potential value for hsa-miRNA-145 analyses. This study involved the evaluation of circulating hsa-miRNA-145 levels in the plasma of Peruvian women using digital dPCR, along with in silico analysis of its metabolic impact on cancer. This study included plasma samples from 30 women residing in Lima (aged 20–67). All individuals had previously received negative breast cancer screening results between 2016 and 2018. We used a chip-based amplification platform (dPCR system) to analyze their hsa-miRNA-145 levels and compare them with those reported in breast cancer patients. These patients had significantly lower levels. In the in silico analysis, 35 target transcripts belonging to signaling and metabolic pathways associated with the variation in hsa-miRNA-145 levels in breast and ovarian cancer were identified. Specifically, hsa-miRNA-145 was predicted to significantly impact calcium, cell proliferation, metastasis, and glucose/glutamine metabolism, with effects on the CAMK2D, EGFR, TP53, hexokinase 2 (HK2), and glutaminase (GLS) genes. This research deepens our understanding of the epigenetic factors involved in breast cancer, including plasma miRNA-145 levels, as well as associated metabolic pathways, which could promote precision medicine for Peruvian cancer patients.

1 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
DODaisy Maria Obispo
Daisy Maria Obispo
OAOscar Acosta
Oscar Acosta
MGMaría L. Guevara-Fujita
María L. Guevara-Fujita
SESusan Echavarria
Susan Echavarria
SESusan Espetia
Susan Espetia
RFRicardo FUJITA
Ricardo FUJITA
Accurate determination of an individual’s unique human leukocyte antigen (HLA) allele holds important significance in evaluating the risk associated with autoimmune and infectious diseases, such as human immunodeficiency virus (HIV) infection. Several allelic variants within the HLA system have been linked to either increased protection or susceptibility in the context of infectious and autoimmune diseases. This study aimed to determine the frequency and association of HLA alleles between people living with HIV (PLHIV) as the case group and HIV-uninfected Peruvian individuals with high-risk behavior of sexual transmission diseases as the control group. Whole exome sequencing (WES) was used to determine high-resolution HLA allelotypes using OptiType and arcasHLA tools. The HLA alleles present in HLA classes I (A, B, and C loci) and II (DPA1, DPB1, DQA1, DQB1 and DRB1 loci) were determined in a cohort of 59 PLHIV (cases) and 44 HIV-uninfected individuals (controls). The most frequent HLA alleles were A*02:01, DPB1*04:02 and DQB1*03:419 at 36%, 30% and 28% prevalence in general population. We found that C*07:01 (p = 0.0101; OR = 10.222, 95% IC: 1.40–74.55), DQA1*03:02 (p = 0.0051; OR = 5.297, 95% IC: 1.48–19.02) and DRB1*09:01 (p = 0.0119; OR = 4.788, 95% IC: 1.39–16.44) showed an association with susceptibility to HIV infection, while DQB1*03:419 (p = 0.0478; OR = 0.327, 95% IC: 0.11–0.96) was associated with protection from HIV infection. Our findings contribute to the knowledge of HLA allele diversity in the Peruvian population (around 70% South American indigenous ancestry), lay the groundwork for further valuable large-scale use of HLA typing and offer a novel association of HIV infection that is relevant to vaccine studies.

19 July 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
KQKaren Eugenia Quispe
Karen Eugenia Quispe
ALBERTO SALAZAR GRANARAALBERTO SALAZAR GRANARA
ALBERTO SALAZAR GRANARA
MTMario Cueva Távara
Mario Cueva Távara
JHJanet Huancachoque
Janet Huancachoque
Diego Segura LoayzaDiego Segura Loayza
Diego Segura Loayza
PCPool Marcos Carbajal
Pool Marcos Carbajal
Multidrug-resistant (MDR) Klebsiella pneumoniae is a critical cause of nosocomial infections associated with high mortality. Of particular concern is the genomic convergence of multidrug resistance and hypervirulence (MDR-hvKP), which represents a severe public health threat. This study characterised the resistome, virulome, and population structure of seven clinical MDR K. pneumoniae isolates collected between 2024 and 2025 across four Peruvian regions (Moquegua, Ucayali, Loreto, and Lima) using whole-genome sequencing (WGS). Genomic analysis identified six distinct sequence types, with the high-risk clone ST307 being the most prevalent (2/7 isolates), consistently associated with the KL102 capsular locus. Remarkably, one isolate from Loreto (oph_54) exhibited a convergent MDR-hvKP genomic profile (ST218, KL57, virulence score 4), carrying yersiniabactin, salmochelin (iro), and aerobactin (iuc) loci alongside multiple resistance determinants. The isolates presented a robust resistome dominated by the extended-spectrum beta-lactamase gene blaCTX-M-15 (5/7) and blaOXA-1, coupled with aac(6′)-Ib-cr and fosA6 genes. Plasmid analysis revealed a predominance of IncFIB(K) replicons. Although exploratory, these findings demonstrate the regional presence of high-risk ST307 lineages and the emergence of convergent MDR-hvKP genomic profiles within the analysed Peruvian hospitals. Immediate and continuous genomic surveillance is urgently required to monitor the potential spread of these highly dangerous, MDR bacterial lineages within these healthcare environments.